Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country

Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017

(2020) Xiaochen Li et al.   BMJ-British Medical Journal

Global Burden of Chronic Respiratory Diseases

(2020) Giovanni Viegi et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease

(2020) David M. G. Halpin et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology

(2019) Amna Saeed et al.   PLoS One

The prevalence of asthma in Iranian adults: The first national survey and the most recent updates

(2018) Mohammad Reza Fazlollahi et al.   Clinical Respiratory Journal

Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom

(2015) Aris Angelis et al.   BMC HEALTH SERVICES RESEARCH

Cystic Fibrosis Pulmonary Guidelines

(2013) Peter J. Mogayzel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries

(2013) Zaheer-Ud-Din Babar et al.   PHARMACOECONOMICS

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Christopher J L Murray et al.   LANCET

Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World

(2010) Laurens M. Niëns et al.   PLOS MEDICINE

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis

(2008) A Cameron et al.   LANCET